Price (delayed)
$0.6601
Market cap
$2.05M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.29
Enterprise value
-$6.53M
InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. The company was founded in 2005 with proprietary
There are no recent dividends present for NVIV.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.